Literature DB >> 8657311

Repression of RNA polymerase III transcription by the retinoblastoma protein.

R J White1, D Trouche, K Martin, S P Jackson, T Kouzarides.   

Abstract

Transcription by RNA polymerase (pol) III is under cell-cycle control, being higher in S and G2 than in G0 and early G1 phases. Many transformed cell types have elevated pol III activity, presumably to sustain sufficient protein synthesis for unrestrained growth. The retinoblastoma tumour-suppressor protein (Rb) restricts cellular proliferation, and is often found mutated in transformed cells. Here we demonstrate that Rb can repress the level of transcription from pol III templates both in vitro and vivo. Analysis of Rb-deficient SAOS2 cells and primary fibroblasts from Rb-/- mice demonstrates elevated levels of pol III activity in the absence of functional Rb protein. Rb-induced repression of pol III activity is alleviated by mutations in the Rb pocket domain that occur naturally in tumours, and by viral transforming proteins that bind and inactivate Rb. These results implicate repression of pol III transcription as a mechanism for Rb-induced growth arrest, and suggest that restraining protein biosynthesis may be important in the prevention of tumour development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8657311     DOI: 10.1038/382088a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  75 in total

1.  Repression of ribosome and tRNA synthesis in secretion-defective cells is signaled by a novel branch of the cell integrity pathway.

Authors:  Y Li; R D Moir; I K Sethy-Coraci; J R Warner; I M Willis
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 2.  Survey and summary: transcription by RNA polymerases I and III.

Authors:  M R Paule; R J White
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

3.  Overlapping functions of the pRb family in the regulation of rRNA synthesis.

Authors:  S Ciarmatori; P H Scott; J E Sutcliffe; A McLees; H M Alzuherri; J H Dannenberg; H te Riele; I Grummt; R Voit; R J White
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

4.  RNA polymerase III transcription factor IIIB is a target for repression by pocket proteins p107 and p130.

Authors:  J E Sutcliffe; C A Cairns; A McLees; S J Allison; K Tosh; R J White
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 5.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.

Authors:  T R Brown; P H Scott; T Stein; A G Winter; R J White
Journal:  Gene Expr       Date:  2000

6.  The retinoblastoma tumor suppressor protein targets distinct general transcription factors to regulate RNA polymerase III gene expression.

Authors:  H A Hirsch; L Gu; R W Henry
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

7.  Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription.

Authors:  J E Sutcliffe; T R Brown; S J Allison; P H Scott; R J White
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

8.  The mitogen-activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB.

Authors:  Zoe A Felton-Edkins; Jennifer A Fairley; Emma L Graham; Imogen M Johnston; Robert J White; Pamela H Scott
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

9.  RB and hbrm cooperate to repress the activation functions of E2F1.

Authors:  D Trouche; C Le Chalony; C Muchardt; M Yaniv; T Kouzarides
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

10.  A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.

Authors:  Lorea Manterola; Elizabeth Guruceaga; Jaime Gállego Pérez-Larraya; Marisol González-Huarriz; Patricia Jauregui; Sonia Tejada; Ricardo Diez-Valle; Victor Segura; Nicolás Samprón; Cristina Barrena; Irune Ruiz; Amaia Agirre; Angel Ayuso; Javier Rodríguez; Alvaro González; Enric Xipell; Ander Matheu; Adolfo López de Munain; Teresa Tuñón; Idoya Zazpe; Jesús García-Foncillas; Sophie Paris; Jean Yves Delattre; Marta M Alonso
Journal:  Neuro Oncol       Date:  2014-01-16       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.